Deal with $5.38 million greenshoe will finance development, expansion
By Devika Patel
Knoxville, Tenn., Nov. 16 - Unilife Corp. priced a $35.89 million public sale of stock with a $5.38 million greenshoe in a prospectus supplement filed Wednesday with the Securities and Exchange Commission.
The company will sell 8.25 million common shares at $4.35 apiece. The price per share is an 8.61% discount to the Nov. 15 closing share price of $4.76.
Jefferies is the bookrunner. Leerink Swann is the co-lead manager, and Griffin Securities, Inc. is the co-manager.
Settlement is expected Nov. 21.
Proceeds will be used for the development and commercial supply of the company's portfolio of advanced drug delivery systems, the expansion of its workforce to support expected customer demands, working capital and other general corporate purposes.
The medical device manufacturer is based in Sydney, Australia.
| Issuer: | Unilife Corp.
|
| Issue: | Common shares
|
| Amount: | $35,887,500
|
| Greenshoe: | $5,383,125
|
| Shares: | 8.25 million
|
| Price: | $4.35
|
| Warrants: | No
|
| Bookrunner: | Jefferies
|
| Pricing date: | Nov. 16
|
| Settlement date: | Nov. 21
|
| Stock symbol: | Nasdaq: UNIS
|
| Stock price: | $4.18 at close Nov. 16
|
| Market capitalization: | $260.71 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
